Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke

Classification and natural history of clinically identifiable subtypes of cerebral infarction

John Bamford, Peter Sandercock, Martin Dennis et al. · The Lancet · 1991 · 3.3K citations

Medicine, Neurology, Neurosurgery +16

Probability of stroke: a risk profile from the Framingham Study.

Philip A. Wolf, Ralph B. D’Agostino, Albert J. Belanger et al. · Stroke · 1991 · 1.8K citations

Medicine, Cardiology, Preventive Medicine +17

Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction

Lars Wilhelmsen, Kurt Svärdsudd, K Korsan-Bengtsen et al. · New England Journal of Medicine · 1984 · 1.7K citations

Life Sciences, Cardiology, Hematology +12

Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause Mortality

Daniel E. Weiner, Hocine Tighiouart, Manish Amin et al. · Journal of the American Society of Nephrology · 2004 · 1.2K citations

Medicine, Cardiology, Nephrology +17

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Carmine Zoccali, Stefanie M. Bode‐Böger, Francesca Mallamaci et al. · The Lancet · 2001 · 1.1K citations

Medicine, Nephrology, Pharmacology +8